Marketwire Rockwell Medical Presents New Data on Proprietary Iron-Delivery Drug SFP at American Society of Nephrology Annual Meeting
Soluble Ferric Pyrophosphate (SFP) is a novel, investigational, continuous iron therapy designed to treat iron deficiency anemia in end-stage renal disease (ESRD) patients. SFP is designed as a continuous replacement treatment delivering small doses of iron during every dialysis session in order to replenish iron lost during the dialysis procedure.      
Remove Frame | VIDEO-LINK